1. Wiggs, Janey L, Pasquale, Louis R. . Genetics of glaucoma. In Human molecular genetics, 26, R21-R27. doi:10.1093/hmg/ddx184. https://pubmed.ncbi.nlm.nih.gov/28505344/
2. Park, Sunmin, Daily, James W, Song, Mi Young, Kwon, Hyuk-Ku. 2020. Gene-gene and gene-lifestyle interactions of AKAP11, KCNMA1, PUM1, SPTBN1, and EPDR1 on osteoporosis risk in middle-aged adults. In Nutrition (Burbank, Los Angeles County, Calif.), 79-80, 110859. doi:10.1016/j.nut.2020.110859. https://pubmed.ncbi.nlm.nih.gov/32619791/
3. Staats, Kim A, Wu, Timothy, Gan, Bing S, O'Gorman, David B, Ophoff, Roel A. 2016. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility. In Journal of dermatological science, 83, 131-7. doi:10.1016/j.jdermsci.2016.04.015. https://pubmed.ncbi.nlm.nih.gov/27245865/
4. Pippin, James A, Chesi, Alessandra, Wagley, Yadav, Hankenson, Kurt D, Grant, Struan F A. 2021. CRISPR-Cas9-Mediated Genome Editing Confirms EPDR1 as an Effector Gene at the BMD GWAS-Implicated 'STARD3NL' Locus. In JBMR plus, 5, e10531. doi:10.1002/jbm4.10531. https://pubmed.ncbi.nlm.nih.gov/34532616/
5. Qian, Xiaoyu, Cai, Jin, Zhang, Yi, Zhong, Xiuying, Gao, Ping. 2024. EPDR1 promotes PD-L1 expression and tumor immune evasion by inhibiting TRIM21-dependent ubiquitylation of IkappaB kinase-β. In The EMBO journal, 43, 4248-4273. doi:10.1038/s44318-024-00201-6. https://pubmed.ncbi.nlm.nih.gov/39152265/
6. Liang, Xiuqing, Bai, Jian, Chen, Baoguang. 2020. Overexpression of EPDR1 has an antitumorigenic effect on breast cancer in vitro. In International journal of clinical and experimental pathology, 13, 2628-2636. doi:. https://pubmed.ncbi.nlm.nih.gov/33165408/
7. Yang, Yue, Zhang, Hanchao, Liu, Zhengdao, Zhao, Faliang, Liang, Guobiao. 2021. EPDR1 is related to stages and metastasize in bladder cancer and can be used as a prognostic biomarker. In BMC urology, 21, 71. doi:10.1186/s12894-021-00843-2. https://pubmed.ncbi.nlm.nih.gov/33902536/
8. Chen, Ruochan, Zhang, Yiya. 2020. EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker. In Journal of cellular and molecular medicine, 24, 12107-12118. doi:10.1111/jcmm.15852. https://pubmed.ncbi.nlm.nih.gov/32935479/
智鼠故事 
